Company · CIK 1809616

# Universe Pharmaceuticals INC

| CIK | [1809616](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001809616) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | F4 |
| Business address | China |
| Listed | UPC (Nasdaq) |
| First annual or quarterly report | 2022-01-31 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-299191 | Shelf Effective | 2026-09-29 | 2026-10-09 | 2 |
| 333-268028 | Shelf Effective | 2022-10-27 | 2024-12-09 | 3 |
| 333-278914 | Registered company Final prospectus | 2024-04-24 | 2024-06-25 | 4 |
| 333-248067 | IPO Final prospectus | 2020-08-17 | 2021-03-24 | 7 |

## Filings

 17

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-10-09 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1809616/999999999526003207/9999999995-26-003207-index.htm) Declared effective | 333-299191 | 9999999995-26-003207 |
| 2026-09-29 | [F-3](https://www.sec.gov/Archives/edgar/data/1809616/000121390026104659/0001213900-26-104659-index.htm) Shelf registered | 333-299191 | 0001213900-26-104659 |
| 2024-12-09 | [424B5](https://www.sec.gov/Archives/edgar/data/1809616/000121390024106939/0001213900-24-106939-index.htm) Shelf takedown | 333-268028 | 0001213900-24-106939 |
| 2024-06-25 | [424B4](https://www.sec.gov/Archives/edgar/data/1809616/000121390024055732/0001213900-24-055732-index.htm) Final prospectus | 333-278914 | 0001213900-24-055732 |
| 2024-06-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1809616/999999999524001783/9999999995-24-001783-index.htm) Declared effective | 333-278914 | 9999999995-24-001783 |
| 2024-05-14 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1809616/000121390024042922/0001213900-24-042922-index.htm) Amendment | 333-278914 | 0001213900-24-042922 |
| 2024-04-24 | [F-1](https://www.sec.gov/Archives/edgar/data/1809616/000121390024035858/0001213900-24-035858-index.htm) Registration filed | 333-278914 | 0001213900-24-035858 |
| 2022-11-15 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1809616/999999999522003304/9999999995-22-003304-index.htm) Declared effective | 333-268028 | 9999999995-22-003304 |
| 2022-10-27 | [F-3](https://www.sec.gov/Archives/edgar/data/1809616/000121390022066745/0001213900-22-066745-index.htm) Shelf registered | 333-268028 | 0001213900-22-066745 |
| 2021-03-24 | [424B4](https://www.sec.gov/Archives/edgar/data/1809616/000121390021017519/0001213900-21-017519-index.htm) Final prospectus | 333-248067 | 0001213900-21-017519 |
| 2021-03-22 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1809616/999999999521001048/9999999995-21-001048-index.htm) Declared effective | 333-248067 | 9999999995-21-001048 |
| 2021-03-10 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1809616/000121390021014541/0001213900-21-014541-index.htm) Amendment | 333-248067 | 0001213900-21-014541 |
| 2021-02-24 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1809616/000121390021011334/0001213900-21-011334-index.htm) Amendment | 333-248067 | 0001213900-21-011334 |
| 2020-12-02 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1809616/000121390020040413/0001213900-20-040413-index.htm) Amendment | 333-248067 | 0001213900-20-040413 |
| 2020-11-17 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1809616/000121390020037560/0001213900-20-037560-index.htm) Amendment | 333-248067 | 0001213900-20-037560 |
| 2020-08-17 | [F-1](https://www.sec.gov/Archives/edgar/data/1809616/000121390020022480/0001213900-20-022480-index.htm) Registration filed | 333-248067 | 0001213900-20-022480 |
| 2020-04-24 | [DRS](https://www.sec.gov/Archives/edgar/data/1809616/000121390020010024/0001213900-20-010024-index.htm) Draft made public | 377-03139 | 0001213900-20-010024 |

[All filings of this company](https://equitycapital.markets/filings?cik=1809616) · [CSV](https://equitycapital.markets/filings.csv?cik=1809616)

---
Source page: https://equitycapital.markets/company/1809616 · Data: U.S. SEC EDGAR · CC BY 4.0